NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The preliminary number of Canadian returns by air and land from the U.S. saw steep declines in July compared to a year prior as the trade war between the two countries continues.Read More